Skip to search.
 FTSE 100 Down 0.03%

Sarepta Therapeutics, Inc. (SRPT)

-NasdaqGS
57.83 Down 3.14(5.15%) 23 Sep 21:00
|After Hours: : 58.05 Up 0.22 (0.38%) 24 Sep 00:53
Prev Close:60.97
Open:60.61
Bid:57.90 x 100
Ask:58.40 x 300
1y Target Est:68.64
Beta:1.70514
Earnings Date:3 Nov - 7 Nov (Est.)
Day's Range:57.23 - 60.70
52wk Range:8.00 - 61.60
Volume:9,680,762
Avg Vol (3m):3,938,130
Market Cap:2.77b
P/E (ttm):N/A
EPS (ttm):-5.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for SRPT at this time.

Comparison

Symbol% ChgMkt Cap
SRPTDown 5.15%2.77b
GSKDown 0.37%105.53b
ALNYDown 1.97%6.48b
ISIS 0.00%6.91b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2,330.73
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-4.17
Quarterly EPS Est (Sep-16) :-1.31
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):69.35

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback